Back
Keros Therapeutics Vs. Tandem Diabetes Care Industry Stock Comparison
Sell
35
KROS
Keros Therapeutics
Last Price:
49.32
Seasonality Move:
4.26%
Sell
46
TNDM
Tandem Diabetes Care
Last Price:
45.38
Seasonality Move:
20.45%
Sell
35
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $49.36. The Score for KROS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Tandem Diabetes Care (TNDM)
is a Sell
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $45.33. The Score for TNDM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- TNDM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $49.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $45.33
The current trend is moderately bearish and TNDM is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.63 | Sell |
Relative Strength Index (14 RSI): | 43.26 | Sell |
Chaikin Money Flow: | 242396 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.68 - 52.44) | Sell |
Bollinger Bands (100): | (51.76 - 64.92) | Sell |
TNDM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.05 | Buy |
Relative Strength Index (14 RSI): | 44.36 | Sell |
Chaikin Money Flow: | 864407 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.03 - 51.67) | Sell |
Bollinger Bands (100): | (25.46 - 44.48) | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.93 | Buy |
20-day SMA: | 49.1 | Buy |
50-day SMA: | 54.38 | Sell |
200-day SMA: | 46.64 | Buy |
8-day EMA: | 48.99 | Buy |
20-day EMA: | 49.97 | Sell |
50-day EMA: | 53.22 | Sell |
200-day EMA: | 50.43 | Sell |
TNDM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.18 | Sell |
20-day SMA: | 49.73 | Sell |
50-day SMA: | 42.42 | Buy |
200-day SMA: | 28.56 | Buy |
8-day EMA: | 47.67 | Sell |
20-day EMA: | 47.9 | Sell |
50-day EMA: | 43.47 | Buy |
200-day EMA: | 34.22 | Buy |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.14 per share, and an increase next year of $0.55 per share.
Keros Therapeutics Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Tandem Diabetes Care Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |